Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Euronext Paris  >  Ipsen    IPN   FR0010259150

IPSEN

(IPN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Upcoming events on IPSEN
04/22/21 Q1 2021 Sales and Revenue Release
05/27/21 Annual General Meeting
07/29/21 Interim 2021 Earnings Release
10/21/21 Q3 2021 Sales and Revenue Release
Past events on IPSEN
02/25/21 ENETS Conference
02/13/21 | 09:00am American society of clinical oncology genitourinary cancers symposium - presentation number : 285
02/13/21 | 09:00am American society of clinical oncology genitourinary cancers symposium - presentation number : 308
02/11/21 | 08:30am FY 2020 Earnings Call
Upcoming sector events for IPSEN
03/08/21 ASTRAZENECA PLC : Bank of America Healthcare Bus Tour
03/09/21 | 01:50pm MERCK & CO., INC. : Barclays Global Healthcare Conference
03/09/21 | 02:25pm BIOMARIN PHARMACEUTICAL INC. : Barclays Global Healthcare Conference
03/09/21 | 03:00pm BRISTOL-MYERS SQUIBB COMPANY : Barclays Global Healthcare Conference
More events
Past sector events for IPSEN
03/06/21 MERCK & CO., INC. : Retroviruses and Opportunistic Infections Conference
03/04/21 | 12:50pm AMGEN INC. : Cowen & Co. Health Care Conference
03/04/21 | 10:30am AMGEN INC. : Acquisition of Five Prime Therapeutics, Inc. by Amgen, Inc. Call
03/04/21 ASTRAZENECA PLC : Goldman Sachs Access to Medicine Index Conference
Annual publications
Annual results201520162017201820192020 (e)
Sales
M €
Released
Forecast
Spread
1 520
1 472
3,2%
1 671
1 626
2,8%
1 909
1 902
0,35%
2 225
2 267
-1,9%
2 576
2 608
-1,2%

2 622
Operating income
(EBITDA)
M €
Released
Forecast
Spread
369
367
0,71%
395
406
-2,8%
556
528
5,3%
729
723
0,93%
944
910
3,7%

910
Operating profit
(EBIT)
M €
Released
Forecast
Spread
323
303
6,4%
356
346
2,9%
450
453
-0,53%
660
640
3,1%
783
775
0,96%

795
Pre-Tax Profit
(EBT)
M €
Released
Forecast
Spread
238
292
-19%
300
329
-8,8%
371
390
-5,0%
494
573
-14%
-38,5
580
-107%

586
Net income
M €
Released
Forecast
Spread
191
213
-10%
226
244
-7,5%
272
293
-7,2%
390
448
-13%
-50,7
465
-111%

462
EPS
Released
Forecast
Spread
2,31
2,46
-6,0%
2,73
2,98
-8,2%
3,28
3,59
-8,7%
4,68
5,44
-14%
-0,61
5,76
-111%

5,54
Announcement Date03/01/201602/23/201702/15/201802/14/201902/13/2020

Quarterly publications
Previous periodNext period
Quarterly results2019 Q42019 S22020 Q12020 Q22020 S12020 Q3 (e)
Sales
M €
Released
Forecast
Spread
702
694
1,1%
1 347
1 374
-2,0%
655
655
-0,13%
614
661
-7,2%
1 268
1 293
-1,9%

650
Operating income
(EBITDA)
M €
Released
Forecast
Spread

69,5










Operating profit
(EBIT)
M €
Released
Forecast
Spread


395
391
1,0%




410
381
7,7%


Pre-Tax Profit
(EBT)
M €
Released
Forecast
Spread


-321
314
-202%




270
367
-26%


Net income
M €
Released
Forecast
Spread


-271
250
-208%




223
299
-25%


EPS
Released
Forecast
Spread


-3,25
3,01
-208%




2,66
3,11
-14%


Announcement Date02/13/202002/13/202004/22/202007/30/202007/30/2020

Financial data source
© 2021 S&P Global Market Intelligence
© 2021 Factset
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise